The Chemours Company CC
$14.58
-$0.45-2.99%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 5.80B | 5.82B | 5.81B | 5.84B | 5.85B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.80B | 5.82B | 5.81B | 5.84B | 5.85B |
| Cost of Revenue | 4.91B | 4.94B | 4.90B | 4.82B | 4.79B |
| Gross Profit | 892.00M | 884.00M | 908.00M | 1.01B | 1.07B |
| SG&A Expenses | 596.00M | 484.00M | 460.00M | 549.00M | 579.00M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.61B | 5.53B | 5.47B | 5.48B | 5.47B |
| Operating Income | 190.00M | 293.00M | 340.00M | 358.00M | 376.00M |
| Income Before Tax | -39.00M | -286.00M | -264.00M | -197.00M | -280.00M |
| Income Tax Expenses | 266.00M | 124.00M | 122.00M | 139.00M | 148.00M |
| Earnings from Continuing Operations | -305.00 | -410.00 | -386.00 | -336.00 | -428.00 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 1.00M | 0.00 | 0.00 | -1.00M | -1.00M |
| Net Income | -304.00M | -410.00M | -386.00M | -337.00M | -429.00M |
| EBIT | 190.00M | 293.00M | 340.00M | 358.00M | 376.00M |
| EBITDA | 532.00M | 647.00M | 703.00M | 691.00M | 703.00M |
| EPS Basic | -2.01 | -2.73 | -2.57 | -2.24 | -2.86 |
| Normalized Basic EPS | -0.08 | 0.33 | 0.47 | 0.54 | 0.62 |
| EPS Diluted | -2.02 | -2.73 | -2.57 | -2.24 | -2.86 |
| Normalized Diluted EPS | -0.08 | 0.33 | 0.47 | 0.54 | 0.62 |
| Average Basic Shares Outstanding | 602.78M | 601.79M | 600.94M | 600.31M | 599.68M |
| Average Diluted Shares Outstanding | 603.24M | 602.25M | 601.41M | 600.77M | 599.68M |
| Dividend Per Share | 0.35 | 0.35 | 0.51 | 0.68 | 0.84 |
| Payout Ratio | -17.76% | -13.17% | -20.21% | -29.38% | -28.90% |